Class 4 Caution in Use on Ibuprofen 200mg And 400mg Tablets

Class 4 Caution in Use on Ibuprofen 200mg And 400mg Tablets

Aspar Pharmaceuticals Limited has informed us that the Patient Information Leaflets (PILs) within the ibuprofen packs below are missing some information identified from post-marketing experience that should be documented in Section 3 (How To Take The Tablets) and Section 4 (Possible Side Effects) of the PIL.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code Product Description Livery Affected Batch
6835151 IBUPROFEN TAB 200MG ASPAR PHARMACEUTICALS Please refer to link above
6835169 IBUPROFEN TAB 200MG ASPAR PHARMACEUTICALS Please refer to link above
1000132 IBUPROFEN TAB 200MG ASPAR PHARMACEUTICALS Please refer to link above
1038892 IBUPROFEN TAB 200MG ASPAR PHARMACEUTICALS Please refer to link above
1077601 IBUPROFEN TAB 200MG ASPAR PHARMACEUTICALS Please refer to link above
1187509 IBUPROFEN TAB 400MG ASPAR PHARMACEUTICALS Please refer to link above
6835177 IBUPROFEN TAB 400MG ASPAR PHARMACEUTICALS Please refer to link above
6835185 IBUPROFEN TAB 400MG ASPAR PHARMACEUTICALS Please refer to link above
1058262 IBUPROFEN TAB 400MG ASPAR PHARMACEUTICALS Please refer to link above
1130509 IBUPROFEN TAB 400MG ASPAR PHARMACEUTICALS Please refer to link above
1130491 IBUPROFEN TAB 400MG ASPAR PHARMACEUTICALS Please refer to link above

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

This is a caution in use only and therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.